Ignite Creation Date:
2025-12-25 @ 4:18 AM
Ignite Modification Date:
2025-12-26 @ 3:19 AM
Study NCT ID:
NCT00057720
Status:
COMPLETED
Last Update Posted:
2011-07-25
First Post:
2003-04-07
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
TLK286 (Telcyta) vs. Doxil/Caelyx or Hycamtin in Platinum Refractory or Resistant Ovarian Cancer
Sponsor:
Telik
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2003-06
Start Date Type:
None
Primary Completion Date:
2006-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2006-12
Completion Date Type:
ACTUAL
First Submit Date:
2003-04-07
First Submit QC Date:
None
Study First Post Date:
2003-04-08
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2011-07-21
Last Update Post Date:
2011-07-25
Last Update Post Date Type:
ESTIMATED